홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Formaldehyde → 4-(4-chloro-2-(3-(dimethylamino)benzo[d]isoxazol-5-yl)phenoxy)-N-(2,4-dimethoxybenzyl)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide

HRID 2203461
노트
인쇄 미리보기

반응식

HRID 2203461 반응식
N[C:2]1[C:6]2[CH:7]=[C:8]([C:11]3[CH:45]=[C:44]([Cl:46])[CH:43]=[CH:42][C:12]=3[O:13][C:14]3[C:19]([F:20])=[CH:18][C:17]([S:21]([N:24]([CH2:30][C:31]4[CH:36]=[CH:35][C:34]([O:37][CH3:38])=[CH:33][C:32]=4[O:39][CH3:40])[C:25]4[S:29][N:28]=[CH:27][N:26]=4)(=[O:23])=[O:22])=[C:16]([F:41])[CH:15]=3)[CH:9]=[CH:10][C:5]=2[O:4][N:3]=1.[CH2:47]=O.[C:49]([BH3-])#[N:50].[Na+]>C(O)(=O)C.C(OCC)(=O)C.[OH-].[Na+]>[Cl:46][C:44]1[CH:43]=[CH:42][C:12]([O:13][C:14]2[C:19]([F:20])=[CH:18][C:17]([S:21]([N:24]([CH2:30][C:31]3[CH:36]=[CH:35][C:34]([O:37][CH3:38])=[CH:33][C:32]=3[O:39][CH3:40])[C:25]3[S:29][N:28]=[CH:27][N:26]=3)(=[O:22])=[O:23])=[C:16]([F:41])[CH:15]=2)=[C:11]([C:8]2[CH:9]=[CH:10][C:5]3[O:4][N:3]=[C:2]([N:50]([CH3:49])[CH3:47])[C:6]=3[CH:7]=2)[CH:45]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 3

HCID 712FormaldehydeHCID 5003444Sodium cyanoborohydrideHCID 903892074-(2-(3-aminobenzo[d]isoxazol-5-yl)-4-chlorophenoxy)-N-(2,4-dimethoxybenzyl)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide

생성물 1

HCID 895553634-(4-chloro-2-(3-(dimethylamino)benzo[d]isoxazol-5-yl)phenoxy)-N-(2,4-dimethoxybenzyl)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide수율 35%

시약·촉매·용매 3

HCID 176Acetic Acid용매HCID 8857Ethyl Acetate용매HCID 14798Sodium Hydroxide용매

실험 절차

To a mixture of 4-(2-(3-aminobenzo[d]isoxazol-5-yl)-4-chlorophenoxy)-N-(2,4-dimethoxybenzyl)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide (0.686 g, 1.0 mmol) and paraformaldehyde (0.30 g, 10.0 mmol) in acetic acid (3 mL) was added sodium cyanoborohydride (0.19 g, 3.0 mmol) and the reaction mixture was stirred at ambient temperature for 16 h. The mixture was diluted with ethyl acetate (100 mL) and 1 M aqueous sodium hydroxide (10 mL) was added. The organic phase was washed with 1 M aqueous sodium hydroxide (10 mL) and brine (10 mL), dried over anhydrous sodium sulphate, filtered and concentrated in vacuo. The residue was purified by column chromatography, eluting with a 25-100% gradient of ethyl acetate in hexanes to afford 4-(4-chloro-2-(3-(dimethylamino)benzo[d]isoxazol-5-yl)phenoxy)-N-(2,4-dimethoxybenzyl)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide as a beige solid 35% yield (0.25 g): MS (ES+) m/z 713.3 (M+1), 715.7 (M+1).

후처리

  1. additionwas added
  2. washThe organic phase was washed with 1 M aqueous sodium hydroxide (10 mL) and brine (10 mL)
  3. dry with materialdried over anhydrous sodium sulphate
  4. filtrationfiltered
  5. concentrationconcentrated in vacuo
  6. customThe residue was purified by column chromatography
  7. washeluting with a 25-100% gradient of ethyl acetate in hexanes

출처 및 근거

ORD 기록
ord-f2ecde9ee41d45f28116ea48c3b20ebc
출처 데이터셋
uspto-grants-2016_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09365578B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트